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Abstract
Background: Genes have been found to influence the age of onset of several diseases and traits.
The occurrence of many chronic diseases, obesity included, appears to be strongly age-dependent.
However, an analysis of potential age of onset genes for obesity has yet to be reported. There are
at least two analytic methods for determining an age of onset gene. The first is to consider a person
affected if they possess the trait before a certain age (an early age of onset phenotype). The second
is to define the phenotype based on the residual from a survival analysis.
Results: No regions provided evidence for linkage at the more stringent level of p < 0.001.
However, five regions showed consistent suggestive evidence for linkage (one marker with p < 0.01
and a second contiguous marker at p < 0.05). These regions were chromosome 1 (280–294 cM)
and chromosome 16 (56–64 cM) for overweight using the survival analysis residual method and
chromosome 13 (102–122 cM), chromosome 17 (127–138 cM), and chromosome 19 (23–47 cM)
for obese before age 35.
Conclusion: Only one region (chromosome 19 at 23–47 cM) showed somewhat consistent
results between the two analytic methods. Potential reasons for inconsistent results between the
two methods, as well as their strengths and weaknesses, are discussed. The use of both methods
together to explore the genetics of the age of onset of a trait may prove to be beneficial in
determining a gene that is linked only to an early age of onset phenotype versus one that
determines age of onset through all age groups.
Background
In the United States, the prevalence of obesity has
increased dramatically in the past several decades. Results
from the Behavioral Risk Factor Surveillance System indi-
cated that obesity prevalence has increased by more than
50% in adults between 1991–1999 [1,2]. According to the
definition of the World Health Organization (WHO),
approximately 6–10% of the population in Westernized
countries is considered obese [3]. Epidemiological studies
have shown that between 30–70% of the variation in
body weight may be attributable to genetic factors [4].
Obesity related traits, such as body mass index (BMI), are
influenced by both genetic and environmental factors.
BMI is an easy, reliable, accurate measurement and is
highly correlated (0.8–0.9) with total fat mass in adults
[5]. A number of studies have estimated the heritability of
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BMI to be 40%-55% [4,6], but estimates greater than 80%
have been found in twin studies.
Mendelian types of obesity have been identified [7],
although the genes that confer susceptibility to the com-
mon form of obesity are largely unknown. Segregation
analyses have provided evidence for a recessive major
gene that accounts for 20–40% of the variance with an
additional 34–42% of the variance attributed to a multi-
factorial component [8,9]. Additional segregation analy-
ses using two-locus models in independent studies have
revealed evidence for two recessive loci that together
account for approximately 64–68% of the variance
[10,11]. In addition, it appears as though some genotypes
may interact with age and sex [12].
The occurrence of many chronic diseases, obesity
included, appears to be strongly age-dependent and it
may be necessary to account for this in linkage studies
designed to detect these genes. A genome-wide linkage
analysis in the Framingham Heart Study population offers
an opportunity to examine both age of onset and ultimate
susceptibility to overweight and obesity, as measured by
body mass index (BMI).
Specifically, this can be addressed by applying two meth-
ods for analyzing the age-dependent genetic factors that
may impact overweight status and/or obesity. The first
method entails restricting the analysis to those with an age
of onset prior to some arbitrary threshold. The second
strategy is a modification of nonparametric analyses such
that it accounts for age-specific occurrence. This latter
method involves defining the trait as a "residual" from a
survival analysis model [13,14]. These two methods are
useful because each will explore different questions; that
is, the restriction analysis will address an early age of onset
phenotype of obesity/overweight, whereas defining a
"residual" examines the age of onset of obesity/over-
weight throughout the life-span.
The objectives of this study are two-fold: 1) To test for
linkage to an early age of onset phenotype of obesity/over-
weight (i.e., BMI) using restriction analysis. This analysis
will reduce age-related heterogeneity in which young
affected individuals possess a susceptibility gene for early
age of onset obesity/overweight that is different from the
disease gene possessed by those who develop the disease
later in life. 2) To test for linkage to the variation of age of
onset of obesity/overweight throughout the life-span by
defining the phenotype (i.e., BMI) as a "residual" in a sur-
vival analysis model. In this case, when the genetic effect
is on the variation in age of onset, the disease allele influ-
ences the age at which the person develops the disorder.
Methods
The Framingham Heart Study data set for the Genetic
Analysis Workshop 13 was utilized to conduct a genome-
wide linkage analysis on 1702 individuals in 330 pedi-
grees. All analyses were performed on sibling pairs using
SIBPAL (S.A.G.E. version 4.2). The GENIBD program
(S.A.G.E. version 4.2) was used for generating single-point
identity-by-descent (IBD) sharing distributions. All of the
default options were used in the GENIBD and SIBPAL
analyses.
In the present study, we used BMI as the measure of obes-
ity/overweight. BMI was calculated as weight (in kg)
divided by the square of the height (in meters). The mean
height was used because height measurements at each
clinic visit may have varied for each subject.
To examine the phenotypic heterogeneity of overweight
and obesity in which a genetic effect is involved in the age
of onset, the analyses were restricted to those with an age
of onset < 35 years. This age of onset was chosen in order
to maximize sample size while minimizing the behavioral
effects of decreasing leisure time physical activity that fre-
quently occur in the 30 s and 40 s (preliminary descriptive
statistics [data not shown] indicated that the minimum
age of onset to provide enough "affected" individuals was
about 35 years). A BMI of > 27 was defined as overweight
and > 30 was defined as obese. Age of onset was the age at
which an individual first met the BMI criteria or, if they
met the BMI criteria at the start of the study, their age at
the baseline visit. The restricted analysis was performed
for the phenotype of overweight and also for the pheno-
type of obesity using the test of mean allele sharing for
binary traits in concordantly affected sibling pairs (in
SIBPAL).
The survival analysis "residual" method uses PROC
LIFETEST (S.A.S. version 8.1) to obtain the cohort and sex-
specific cumulative incidence at the age a person was first
affected or, if unaffected, the age at the last visit. This
cumulative incidence was subtracted from the affection
status (0 for unaffected and 1 for affected) to obtain the
"residual" (the adjusted affection status). This approach
was performed on the phenotypes of overweight and of
obesity using the traditional Haseman-Elston regression
model (SIBPAL).
Results
A total of 94 sibling pairs concordantly overweight before
age 35 and 28 sibling pairs concordantly obese before age
35 were included in the restricted analysis and 1500 sib-
ling pairs were in both survival analyses. The mean BMI at
baseline for Cohort 1 (the original Framingham cohort)
was 27 (mean baseline age of 42 years) and for Cohort 2
(the offspring of the original Framingham cohort) was 26BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S90
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(mean baseline age of 33 years). Selected results from sin-
gle-point linkage analysis for the phenotypes of over-
weight and obesity are shown in Table 1. Contiguous
regions of chromosomes are indicated by an partial lines.
Only markers that achieved a significance level of p < 0.01
or markers with p < 0.05 that were clustered together were
reported.
Table 1: Summary of significant linkage findings for overweight and obesity using two analytic approaches.
p-Values
Overweight Obese













1 GATA109 119.79 (12) 0.04A 0.93 0.05 0.60
1 GATA6A05 125.17 (13) 0.02A 0.44 0.05 0.49
1 203yg9 280.12 (30) 0.50 0.02A 0.38 0.25
1 GATA4A09 294.45 (31) 0.92 0.007B 0.50 0.63
3 ATA10H11 76.97 (9) 0.04A 0.59 0.02A 0.64
3 GATA148E04 98.15 (11) 0.03A 0.76 0.29 0.32
5 GATA21D04 63.39 (11) 0.88 0.04A 0.65 0.84
5 GATA52A12 92.30 (13) 0.70 0.02A 0.73 0.67
5 ATA4D10 125.22 (17) 0.22 0.14 0.11 0.03A
5 GATA62A04 141.70 (19) 0.64 0.22 0.66 0.047A
6 242zg5 181.68 (20) 0.003B 0.72 0.19 0.18
7 GATA137H02 31.97 (3) 0.92 0.19 0.61 0.003B
7 GATA41G07 36.30 (4) 0.92 0.04A 0.88 0.19
7 GGAA3F06 45.24 (5) 0.92 0.27 0.36 0.03A
7 GATA13G11 54.60 (6) 0.76 0.31 0.003B 0.15
13 261yg5 102.47 (11) 0.36 0.31 0.02A 0.85
13 309va9 122.40 (12) 0.11 0.31 0.001B 0.27
16 GATA71H05 56.14 (5) 0.42 0.02A 0.10 0.22
16 GGAA3G05 63.74 (6) 0.80 0.0098B 0.28 0.08
16 GATA81D12 95.47 (10) 0.80 0.003B 0.42 0.48
17 044xg3 127.48 (15) 0.15 0.37 0.006B 0.92
17 217yd10 138.03 (16) 0.11 0.18 0.01A 0.92
19 GATA21G05 23.03 (2) 0.64 0.72 0.003B 0.06
19 GATA66B04 46.82 (4) 0.66 0.31 0.04A 0.82
19 Mfd238 111.74 (11) 0.10 0.39 0.001B 0.41
20 GGAA7E02 44.46 (5) 0.03A 0.60 0.04A 0.14
20 GATA42A03 61.63 (7) 0.04A 0.56 0.59 0.39
20 GATA45B10 89.70 (10) 0.46 0.29 0.04A 0.24
20 046xf6 108.32 (11) 0.39 0.38 0.03A 0.48
Ap < 0.05 Bp < 0.01 Sections divided by partial lines indicate contiguous markers.BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S90
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No regions provided evidence for linkage at the more
stringent level of p < 0.001. The results for the phenotype
of overweight before age 35 provide suggestive evidence for
linkage to regions on chromosome 6 (182 cM), with weak
evidence for linkage to chromosome 1 (120–125 cM),
chromosome 3 (77–98 cM), and chromosome 20 (44–62
cM). The results for the phenotype of overweight using sur-
vival analysis residual provide suggestive evidence for link-
age to chromosome 1 (280–294 cM) and chromosome 16
(25–64 and 95 cM), with weak evidence for linkage to
chromosome 5 (63–92 cM). The results for the phenotype
of obese before age 35 provide suggestive evidence for link-
age to chromosome 7 (55 cM), chromosome 13 (102–
122 cM), chromosome 17 (127–138 cM), and chromo-
some 19 (23–47 and 112 cM), with weak evidence for
linkage on chromosome 20 (90–108 cM). The results for
the phenotype of obese using survival analysis residual pro-
vide suggestive evidence for linkage to chromosome 7
(32–45 cM) with weak evidence for linkage on chromo-
some 5 (125–142 cM).
Discussion
The affected relative/sib pair approach has been widely
used in linkage analysis. One of the major advantages of
this approach is that it is not affected by age-related pene-
trance (variable age of onset) because all individuals in
the analysis are affected. However, there are at least two
situations in which this approach alone is not sufficient.
First, phenocopies that appear to be identical to a genetic
trait but are caused by nongenetic factors may decrease the
power of an affected relative/sib-pair analysis, making it
less than ideal. Second, phenotypic heterogeneity (where
different genes cause different ages of onset) may lead to
two affected relative/sibling pairs having different ages of
onset due to different genes and, thus, a decrease in the
power to detect linkage. Therefore, it is of interest to find
an analytic approach that addresses these issues. Restrict-
ing the analysis to the phenotype of early age of onset of
obesity/overweight (<35 years) attempts to reduce the
phenotypic heterogeneity due to differences in age of
onset. Another aim of this analytic approach is to "weed
out" phenocopies of obesity/overweight that may occur
later in life and may be caused by other genetic or environ-
mental factors. The survival analysis residual method
attempts to detect a genetic effect on the age of onset of
obesity/overweight. This method accounts for cohort, sex,
and age-specific risk for obesity/overweight in the sample
population, by determining the cumulative incidence in
the sample for a particular cohort, sex, and age. For exam-
ple, the value of the residual (the adjusted affection sta-
tus) would be 0.8 for an affected person when the cohort,
sex- and age-specific cumulative incidence was 0.2 (fewer
people had become obese/overweight in their group) and
0.2 if the cumulative incidence was 0.8 (more people had
become obese/overweight in their group). The person
with the residual of 0.8 could potentially have a genetic
risk factor predisposing them to an earlier age of onset
than the person with the residual of 0.2. The restriction
method would be expected to perform well in the case of
an early age of onset phenotype that is etiologically dis-
tinct from later age of onset phenotypes. The survival
analysis residual method would be expected to be more
robust when there is a genetic effect on the variation in the
age of onset throughout the life-span. In this case, loss of
information would occur by using an age of onset cut-off
to restrict the analysis. A strong genetic effect on age of
onset throughout the life-span (including ages less than
the cut-off age of the restricted analysis) may be expected
to produce consistent results between both analytic
methods.
In our genome-wide linkage analysis, five regions showed
consistent suggestive evidence for linkage (one marker
with p < 0.01 and a second contiguous marker at p <
0.05). These regions were chromosome 1 (280–294 cM)
and chromosome 16 (56–64 cM) for overweight using the
survival analysis residual method and chromosome 13
(102–122 cM), chromosome 17 (127–138 cM), and chro-
mosome 19 (23–47 cM) for obese before age 35.
The results on chromosomes 1 and 16 for overweight
using the survival analysis residual method were not rep-
licated in the affected sibling pairs with age of onset of
overweight before 35. This region may be responsible for
a genetic effect on age of onset of overweight in the mid-
dle and later years of life when, in general, a more seden-
tary lifestyle has been adopted. This may be the case if the
region was involved in a gene × environment interaction
in which a sedentary lifestyle in addition to the gene was
necessary to result in moderate weight gain. Another
explanation is that the number of affected sibling pairs
was too small to detect linkage, whereas using all the sib-
ling pairs in the survival analysis residual method (a con-
tinuous trait) resulted in more power to detect linkage.
The results on chromosomes 13 and 17 for obese before
age 35 were not replicated by the survival analysis residual
method. This may indicate that chromosomes 13 and 17
are linked with a distinct phenotype of obesity in which
the age of onset is before 35 years of age. These regions
may even be responsible for a phenotype of childhood or
adolescent obesity, although we did not have enough peo-
ple in these age groups to test this hypothesis.
Another explanation for the inconsistency of the results
on chromosomes 13 and 17 could be strong environmen-
tal determinants of shifting from normal weight or over-
weight to obese in the middle and later years of life (age
of onset ≥ 35). If a gene(s) plays a role in the age at which
one becomes obese, it may be more easily detected at aPublish with BioMed Central    and   every 
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younger age in which people tend to be more physically
active (the environmental exposure of a sedentary lifestyle
is absent). As many people become more sedentary in
their 30s and beyond, weight gain may occur due to excess
energy intake even in the absence of genetic factors, mak-
ing it more difficult to detect a genetic effect. The stratified
analysis of people who were obese at a younger age would
not be as affected by this shift in environmental exposure.
This approach would perform the linkage analysis on a
more homogeneous population of affected individuals.
Conversely, although the survival analysis residual
method accounts for excess energy intake with increasing
age in the population through adjustment of the affection
status by the cumulative incidence, all individuals are
included in the analysis, potentially creating a more heter-
ogeneous sample with respect to etiology of the pheno-
type. Hypothetically, a discordant sibling pair in which
one sibling became affected at age 40 entirely due to
excess energy intake (assume no genetic susceptibility)
while the other sibling was unaffected at age 40 and did
not have an excess energy intake would tend to "wash
out" a true genetic effect on the phenotype in another sib-
ling pair.
There was one region (chromosomes 19 at 22 cM) in
which both analytic methods detected evidence for link-
age to the phenotype of obesity. Consistency of results
from the two analytic methods may have occurred due to
a genetic effect on age of onset throughout the lifespan
including ages < 35.
Overall, both analytic methods have strengths and weak-
nesses and the use of both methods together to explore
the genetics of the age of onset of a trait may prove to be
beneficial in determining a gene that is linked only to an
early age of onset phenotype versus one that determines
age of onset through all age groups. The survival analysis
residual method allows for the entire sample to be ana-
lyzed, whereas the stratification method limits one to a
smaller sample size, which reduces one's power. Addition-
ally, stratification may lose information from siblings
who are not affected at the time of the visit, but may later
become affected, whereas the survival analysis residual
method uses all siblings and adjusts their affection status
by the cumulative incidence of the trait. However, stratifi-
cation by age may be better able to detect linkage if there
is a strong environmental component in ages greater than
the stratification cutoff age.
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